© 1991

Lectins and Cancer

  • Hans Joachim Gabius
  • Sigrun Gabius
Conference proceedings

Table of contents

  1. Front Matter
    Pages I-X
  2. G. Uhlenbruck, F. G. Hanisch, W. E. G. Müller
    Pages 13-26
  3. W. E. G. Müller, J. M. S. Forrest, S.-H. Chang, B. E. Weiler, H. Schäcke, E. Matthes et al.
    Pages 27-40
  4. I. Damjanov, M. Sobrinho-Simoes
    Pages 41-51
  5. R. Heicappell, H. Buszello, S. Gabius, R. Ackermann, H.-J. Gabius
    Pages 105-122
  6. P. L. Mann, D. Eshima, D. M. Bitner, R. H. Griffey, R. Wenk, J. L. Born et al.
    Pages 179-206
  7. S. S. Joshi, K. C. Komanduri, S. Gabius, H.-J. Gabius
    Pages 207-216
  8. W. Hiddemann, B. Wörmann, M. Zühlsdorf, C. Reuter, E. Schleyer, C. Busemann et al.
    Pages 229-235
  9. N. Yamazaki, S. Kojima, S. Gabius, H.-J. Gabius
    Pages 251-261

About these proceedings


Molecular recognition undoubtedly governs any aspect of cellular interaction. To understand tumor cell growth regulation and spread, analysisof protein carbohydrate interactions can contribute to lead to the establishment of rational methods for diagnosis and therapy. Chemically and biochemically optimized preparation of adequate tools, their application for localization of receptor (tissue lectin) and ligand (cellular glycoconjugate) pairs in tumor cells and tumor sections and the usefulness of a lectin from a plant extract as potent immunomodulator indicate the prospect for a place of such techniques in pathology and oncology.


Glycoproteine Lektine Tumordiagnose Tumortherapie cell interaction glycoproteins lectins regulation tumor diagnosis tumor therapy zelluläre Wechselwirkungen

Editors and affiliations

  • Hans Joachim Gabius
    • 1
  • Sigrun Gabius
    • 2
  1. 1.Max-Planck-Institut für experimentelle MedizinGöttingenGermany
  2. 2.Abteilung Hämatologie/OnkologieMedizinische UniversitätsklinikGöttingenGermany

Bibliographic information

Industry Sectors
Health & Hospitals
Oncology & Hematology